Pharma Mar, S.A. (OTCMKTS:PHMMF) Sees Significant Growth in Short Interest

Pharma Mar, S.A. (OTCMKTS:PHMMF) was the target of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 32,700 shares, a growth of 43.4% from the February 13th total of 22,800 shares. Approximately 0.2% of the company’s shares are short sold. Based on an average daily volume of 100 shares, the short-interest ratio is presently 327.0 days.

Pharma Mar Stock Performance

PHMMF opened at $102.08 on Tuesday. The business has a 50 day simple moving average of $92.66 and a two-hundred day simple moving average of $76.00. The company has a quick ratio of 2.01, a current ratio of 2.55 and a debt-to-equity ratio of 0.14. Pharma Mar has a one year low of $26.85 and a one year high of $105.60.

About Pharma Mar

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.